BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12702959)

  • 1. The natural history of dysplasia and cancer in esophagitis and Barrett esophagus.
    Spechler SJ
    J Clin Gastroenterol; 2003; 36(5 Suppl):S2-5; discussion S26-8. PubMed ID: 12702959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical and histopathologic focus on Barrett esophagus and Barrett-related dysplasia.
    Voltaggio L; Montgomery EA; Lam-Himlin D
    Arch Pathol Lab Med; 2011 Oct; 135(10):1249-60. PubMed ID: 21970480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett esophagus: diagnostic challenges.
    Hagen CE; Lauwers GY; Mino-Kenudson M
    Semin Diagn Pathol; 2014 Mar; 31(2):100-13. PubMed ID: 24815936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus, dysplasia, and adenocarcinoma.
    Haggitt RC
    Hum Pathol; 1994 Oct; 25(10):982-93. PubMed ID: 7927321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Barrett's esophagus: diagnosis and therapy].
    Schmassmann A; Gebbers JO
    Praxis (Bern 1994); 2005 May; 94(21):861-8. PubMed ID: 15966485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus.
    Katada N; Hinder RA; Smyrk TC; Hirabayashi N; Perdikis G; Lund RJ; Woodward T; Klingler PJ
    Arch Surg; 1997 Jul; 132(7):728-33. PubMed ID: 9230856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in Barrett esophagus.
    Dunbar KB; Spechler SJ
    Mayo Clin Proc; 2014 Jul; 89(7):973-84. PubMed ID: 24867396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma.
    Oberg S; Wenner J; Johansson J; Walther B; Willén R
    Ann Surg; 2005 Jul; 242(1):49-54. PubMed ID: 15973101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
    Herszenyi L; Hritz I; Pregun I; Sipos F; Juhasz M; Molnar B; Tulassay Z
    World J Gastroenterol; 2007 Feb; 13(5):676-82. PubMed ID: 17278189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett esophagus: will effective treatment prevent the risk of progression to esophageal adenocarcinoma?
    Sharma P
    Am J Med; 2004 Sep; 117 Suppl 5A():79S-85S. PubMed ID: 15478857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux and cancer.
    Turcotte S; Duranceau A
    Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of Barrett's esophagus: 1980-2003.
    Csendes A
    World J Surg; 2004 Mar; 28(3):225-31. PubMed ID: 14961203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foveolar type dysplasia in Barrett esophagus.
    Brown IS; Whiteman DC; Lauwers GY
    Mod Pathol; 2010 Jun; 23(6):834-43. PubMed ID: 20228780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
    Yang L; Francois F; Pei Z
    Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Barrett's esophagus free of dysplasia.
    DeMeester SR
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.